In the days of spike medicine
Release time:
2023-07-14
The footsteps of time are silent and pass inadvertently. Just as I often forget that I have been working in Jianfeng Pharmaceutical for two years and am no longer one of the thousands of students.
To this day, I still feel firm and warm when I recall my journey to the peak. There is no indecisive entanglement, and no anxious waiting. When the classmates around me are still at a loss for where I will go after graduation, I have already made my goal clear. The new environment, the magnificent office building, the huge and clean factory area, and the enthusiastic colleagues... all make me full of enthusiasm and expectation for my future work.
After a period of adaptation, I gradually got used to the working environment and gradually got my own working rhythm. Although I have encountered problems that are unable to solve and feel depressed about my lack of knowledge, leaders and colleagues can always give a helping hand in time. When the problem was solved with their help, I also felt the mutual help among my colleagues.
I am very clear that the job requires me to have a high sense of responsibility and keen observation, and maintaining a high degree of concentration is the basic professional quality. What struck me in particular was that the habits formed at work were gradually affecting my lifestyle. In the past, at home, I often put things casually, and the room sometimes looked messy. After work, because of the fixed management, each item had a fixed location, so as to ensure the cleanliness and freshness of the office area. After getting into the habit, I also used the same method at home. Not only did the items be placed in order, but also the rush to find things temporarily disappeared.
Some time ago, I was a member of the Pharmaceutical Industry Team and participated in the "Spike Cup" basketball match organized by the group company. Although I did not achieve the most ideal results, the pictures of my colleagues unreservedly contributing vitality, passion and energy on the field are deeply engraved in my mind. The hard work on the field also shows the spirit of "determined to rise to the top and climb the peak forever", and shows the strong cultural and sports atmosphere of the enterprise and the collective sense of honor of the peak people.
I love my post, and I am willing to enrich myself and contribute my energy and enthusiasm to my post. Although the time to join the peak is still short, I have not been able to feel the ups and downs of the enterprise for decades, but as Mr. Yu Qiuyu said: I have no time to participate in your past, and I will accompany you to the end in your future.
I hope that I can achieve a better self on the way to push forward the peak and courage! (Ye Yujing, Pharmaceutical Production Department)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page